General anesthesia with an injectable 8% v/v sevoflurane lipid emulsion administered intravenously to dogs
Date
2016
Authors
Natalini, C.
Da Silva Serpa, P.
Cavalcanti, R.
Polydoro, A.
Griffith, J.
Santos, L.
Nicholson, A.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Veterinary Anaesthesia and Analgesia, 2016; 43(3):271-280
Statement of Responsibility
Claudio C Natalini, Priscila B Da Silva Serpa, Ruben L Cavalcanti, Alexandre S Polydoro, Joanna E Griffith, Luiz CP Santos, and Anthony Nicholson
Conference Name
Abstract
Objective: To evaluate the potential of an intravenous (IV) sevoflurane formulation for maintenance of general anesthesia in dogs. Study design: Prospective crossover design. Animals: Six healthy, mature, mixed-breed dogs, four males and two females, weighing 11.7 ± 3.4 kg. Methods: Anesthesia was induced and maintained with propofol IV for instrumentation. Baseline measurements were recorded before administration of either sevoflurane in oxygen (Sevo-Inh) or lipid-emulsified sevoflurane 8% v/v in 30% Intralipid IV (Sevo-E), 0.5 mL kg−1 over 5 minutes followed by an infusion at 0.1–0.3 mL kg−1 minute−1. Dogs were breathing spontaneously. The ‘up-and-down’ technique was used to determine the minimum alveolar concentration (MAC) of sevoflurane. Over 120 minutes, a tail clamp was applied every 15 minutes and sevoflurane administration was adjusted depending on the response. End-tidal sevoflurane concentration and variables were recorded at 30, 60, 90, and 120 minutes: heart rate (HR), systemic arterial pressure (sAP), respiratory rate (fR), end-tidal carbon dioxide tension, hemoglobin oxygen saturation (SaO2), arterial pH and blood gases, blood urea nitrogen, alanine aminotransferase, creatine kinase, gamma-glutamyl transferase, and aspartate aminotransferase. Results: There were no significant differences between treatments for HR, sAP, fR, SaO2, and biochemical variables (p > 0.05). pH and inline imagewere significantly decreased, and PaCO2 increased from baseline in Sevo-E (p < 0.05). MAC was significantly lower for Sevo-E than for Sevo-Inh, although the required dose of sevoflurane (g hour−1) to maintain general anesthesia was not significantly different between treatments. Conclusions and clinical relevance: Administration of 8% v/v sevoflurane lipid emulsion IV was effective in maintaining general anesthesia in dogs, but resulted in moderate cardiopulmonary depression, metabolic and respiratory acidosis. The amount of sevoflurane (g hour−1) required to maintain general anesthesia was significantly lower for inhaled than for IV sevoflurane.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2015 Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia and Analgesia